You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 7, August 17, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Rheumatology
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Folate and Vitamin B12 for Hip Fracture Prevention After Stroke

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Sato and colleagues1 reported the first evidence that treatment of elderly patients with hemiplegia following stroke and high levels of plasma homocysteine, using folate and mecobalamin (vitamin B12), decreases plasma homocysteine levels and markedly reduces the risk of hip fracture. This treatment did not affect bone mineral density (BMD) or fall frequency in these patients, consistent with a recent epidemiological study2 that found that high homocysteine levels in blood were associated with an increased risk of nonvertebral fractures in older people independent of BMD or recent falls. These findings suggest that the reduced fracture risk results from an improvement of bone quality, possibly countering inhibition of collagen cross-linking by homocysteine.1-2 However, homocysteine levels are closely linked to vitamin B12 levels, and serum vitamin B12 levels in these patients were low at baseline and markedly increased after the treatment; therefore, vitamin B12 itself might be directly . . . [Full Text of this Article]

Toshihiro Sugiyama, MD, PhD
toshihiro.sugiyama@chive.ocn.ne.jp

Hiroshi Tanaka, MD, PhD; Toshihiko Taguchi, MD, PhD
Department of Orthopedic Surgery
Yamaguchi University School of Medicine
Yamaguchi, Japan



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Folate and Vitamin B12 for Hip Fracture Prevention After Stroke—Reply
Yoshihiro Sato, Yoshiaki Honda, Jun Iwamoto, Tomohiro Kanoko, and Kei Satoh
JAMA. 2005;294(7):792.
EXTRACT | FULL TEXT  

Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke: A Randomized Controlled Trial
Yoshihiro Sato, Yoshiaki Honda, Jun Iwamoto, Tomohiro Kanoko, and Kei Satoh
JAMA. 2005;293(9):1082-1088.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli
Sugiyama et al.
J Endocrinol 2007;194:213-222.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.